U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07155902) titled 'Implementing WHO HEARTS-D Guidelines in Bangladesh for Diabetes Control and Prevention' on July 10.
Brief Summary: Type-2 diabetes (T2D) is rising at an alarming rate in the low- and middle-income countries (LMIC). This rapid increase in the T2D burden has a particular impact on cities, where more than half the LMIC populations currently live and where 3 out of 4 people with T2D reside. In response to this growing global challenge, the World Health Organization (WHO) has emphasized (a) the need for an equitable and sustained improvement in the detection, treatment, and control of T2D, and (b) a rapid implementation of the WHO's evid...